Description
Description: Halaven contains eribulin mesylate, a chemotherapy medication used for breast cancer and liposarcoma.
Contents: Each vial contains 0.44mg/ml of eribulin mesylate in a sterile solution for injection.
Uses: Treatment of metastatic breast cancer.
How it Works: It disrupts microtubule function, inhibiting cell division and leading to cancer cell death.
Directions for Use: intravenously under medical supervision.
Side Effects:
- Fatigue
- Nausea
- Neutropenia (low white blood cell count)
Precautions: Regular blood tests to monitor blood counts and liver function.
There are no reviews yet.